Cargando…
The Ameliorative Effect of Empagliflozin in Vigabatrin-Induced Cerebellar/Neurobehavioral Deficits: Targeting mTOR/AMPK/SIRT-1 Signaling Pathways
Introduction. Vigabatrin (VGB) is an antiepileptic drug that acts to irreversibly inhibit the γ-aminobutyric acid (GABA) transaminase enzyme, elevating GABA levels. Broad studies have established that long-term treatment and/or high doses of VGB lead to variable visual defects. However, little atten...
Autores principales: | Amer, Rabab M., Eltokhy, Amira Kamel, Elesawy, Rasha Osama, Barakat, Amany Nagy, Basha, Eman, Eldeeb, Omnia Safwat, Aboalsoud, Alshimaa, Elgharabawy, Nancy Mohamed, Ismail, Radwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229258/ https://www.ncbi.nlm.nih.gov/pubmed/35744783 http://dx.doi.org/10.3390/molecules27123659 |
Ejemplares similares
-
Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat
por: El-Deeb, Omnia Safwat, et al.
Publicado: (2023) -
Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms
por: Faulkner, Michele A., et al.
Publicado: (2011) -
Treatment of refractory complex partial seizures: role of vigabatrin
por: Waterhouse, Elizabeth J, et al.
Publicado: (2009) -
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010) -
Vigabatrin and Visual Field Defects in Pediatric Epilepsy Patients
por: You, Su Jeong, et al.
Publicado: (2006)